Treatment Indications: structural facial contouring and volumizing in high‑support zones (cheekbones, chin, jawline, nasal bridge);, correction of severe volume loss and deep facial depressions;, restoration of facial architecture and symmetry in cases of pronounced atrophy;, achieving a pronounced lifting effect via deep‑layer volumization
Release form: 1 × 1.1 mL pre‑filled sterile glass syringe
Indications: volumizing and structural contouring in deep subcutaneous and supraperiosteal layers;, restoration of major volume deficits and facial skeletal support;, smoothing deep depressions, folds, and scars;, providing maximum shape retention, viscoelasticity, and lifting power with minimal migration (effect duration ~8–12 months)